TAG ARCHIVES FOR human subjects research

28
Aug2016

In Case You Missed It (ICYMI): From time-to-time, PRIM&R will feature particularly well-received posts from the recent past. These posts remain timely as topics of discussion in the fields of research ethics, human subjects protections, or animal care and use. Highlighting them now enables readers who may have missed them a chance to read and comment. In this ICYMI, AER12 poster presenter Brandon Brown follows up on his initial findings regarding the incentives used to encourage participation in human subjects research. Read more

25
Aug2016

In this month’s installment of PRIM&R’s featured member interviews, we hear from Maureen Greene, a longtime PRIM&R member working in human subjects and animal research. This series is intended to let our community get to know our membership and hear about the impact they make through their daily work. Read on to hear from Maureen!

PRIM&R: When and why did you join the field? 
Maureen Greene (MG): I joined the field of research in 1985 when I had the inquiring mind to ask: Why? Early in [...] Read more

24
Aug2016

In Case You Missed It (ICYMI): From time-to-time, Ampersand will feature particularly well-received posts from the recent past.  These posts remain timely as topics of discussion in the fields of research ethics, human subjects protections, or animal care and use. Highlighting them now enables readers who may have missed them a chance to read and comment. In this ICYMI, part of a series of posts working through the Notice of Proposed Rulemaking for revisions to the Federal Policy for the Protection of Human Subjects, PRIM&R Executive Director Elisa Hurley explains the impetus for [...] Read more

12
Aug2016

On August 2, 2016, the Department of Health and Human Services (DHHS) Office for Human Research Protections (OHRP) and the Food and Drug Administration (FDA) jointly released draft guidance on institutional review board (IRB) written procedures. The guidance is “intended for…IRBs and institutions responsible for review and oversight of human subject research under the HHS or FDA regulations, or both.” Read more

5
Aug2016

This week’s Research Ethics Roundup explores ClinicalTrials.gov transparency issues, a potentially controversial citywide study of a new procedure for gunshot and stabbing victims in Philadelphia, charges against an Indian drug developer accused of fraudulent research, and a rebuttal to researchers who have resisted including female mice and rats in pain research. Read more

Page 5 of 34« First...34567...102030...Last »